<p>Hendley &amp; Co. Inc. 在最近向證券交易委員會（SEC）提交的 13F 表格中披露，在第二季度將其在史賽克公司的股份提高了 60.3%。該公司在季度內額外購買了 5,274 股後，持有該醫療科技公司 14,018 股股票。史賽克約佔 Hendley &amp; Co. Inc. 投資組合的 1.9%，使其成為該公司第 18 大持倉。根據 Hendley &amp; Co. Inc. 最近向證券交易委員會（SEC）提交的文件，其在史賽克的持股價值為 5,546,000 美元。</p>
<ul>
<li>如果你只能持有 3 項投資一輩子，請考慮這些</li>
</ul>
<p>其他對沖基金最近也增加或減少了在該公司的股份。Mogy Joel R Investment Counsel Inc. 在第一季度將其在史賽克的持倉提高了 3.4%。Mogy Joel R Investment Counsel Inc. 現在持有 98,216 股該醫療科技公司的股票，價值 36,561,000 美元，在此期間又購買了 3,218 股。Ferguson Wellman Capital Management Inc. 在第一季度將其在史賽克的持倉提高了 1.9%。Ferguson Wellman Capital Management Inc. 現在持有 174,871 股該醫療科技公司的股票，價值 65,096,000 美元，在此期間又購買了 3,341 股。Harbor Capital Advisors Inc. 在第一季度購買了價值約 1,840,000 美元的史賽克新股份。Mar Vista Investment Partners LLC 在第一季度將其在史賽克的股份增加了 10.2%。Mar Vista Investment Partners LLC 現在持有 90,187 股該醫療科技公司的股票，價值 33,572,000 美元，在上個季度又收購了 8,353 股。最後，聯合服務汽車協會在第一季度購買了價值約 2,857,000 美元的史賽克新股份。77.09% 的股票由對沖基金和其他機構投資者持有。</p>
<h2>史賽克股票上漲 0.8%</h2>
<p>史賽克股票週三開盤價為 369.14 美元。該公司的速動比率為 1.06，流動比率為 1.78，債務與股本比率為 0.70。該公司的市值為 1411.2 億美元，市盈率為 48.89，市盈增長比率為 2.64，貝塔值為 0.94。史賽克公司的 52 周低點為 329.16 美元，52 周高點為 406.19 美元。該公司的 50 日移動平均價格為 381.50 美元，200 日移動平均價格為 378.86 美元。</p>
<ul>
<li>3 只幫助將人工智能引入醫療保健的股票</li>
</ul>
<p>史賽克（NYSE:SYK - 獲取免費報告）最近在 7 月 31 日（星期四）公佈了季度財報。該醫療科技公司報告季度每股收益為 3.13 美元，超出市場共識預期的 3.07 美元，超出 0.06 美元。該公司在季度內的收入為 60.2 億美元，而分析師預期為 59.2 億美元。史賽克的股本回報率為 23.94%，淨利潤率為 12.25%。與去年同期相比，史賽克的季度收入增長了 11.1%。在去年同期，該公司每股收益為 2.81 美元。史賽克已將其 2025 財年的指導目標設定為 13.400-13.600 每股收益。平均而言，賣方分析師預測史賽克公司本財年的每股收益為 13.47 美元。</p>
<h2>史賽克宣佈分紅</h2>
<p>該公司最近還宣佈了季度分紅，將於 10 月 31 日（星期五）支付。9 月 30 日（星期二）登記的股東將獲得 0.84 美元的分紅。這相當於年化 3.36 美元的分紅，收益率為 0.9%。除息日為 9 月 30 日（星期二）。史賽克的派息比率目前為 44.50%。</p>
<h2>分析師設定新目標價</h2>
<ul>
<li>波士頓科學：為什麼這家醫療科技巨頭沒有放慢腳步</li>
</ul>
<p>多家券商最近對 SYK 發佈了報告。BTIG Research 在 7 月 14 日（星期一）的研究報告中重申了對史賽克股票的 “買入” 評級。Redburn Partners 在 9 月 18 日（星期四）的研究報告中將史賽克的目標價設定為 420.00 美元。Weiss Ratings 在 9 月 27 日（星期六）的研究報告中重申了對史賽克股票的 “買入（b-）” 評級。富國銀行在 8 月 1 日（星期五）的研究報告中將史賽克的目標價從 435.00 美元上調至 445.00 美元，並給予該股票 “超配” 評級。最後，Rothschild Redb 在 9 月 18 日（星期四）的研究報告中將史賽克的評級上調至 “持有”。十五位投資分析師對該股票給予了買入評級，六位分析師對該公司給予了持有評級。根據 MarketBeat.com 的數據，該公司的共識評級為 “適度買入”，平均目標價為 430.10 美元。</p>
<p><strong>閲讀我們關於史賽克的最新研究報告</strong></p>
<h2>內部買賣</h2>
<p>在其他史賽克新聞中，董事 Ronda E. Stryker 於 8 月 6 日（星期三）出售了 200,000 股史賽克股票，交易發生在該股票的平均價格為 376.45 美元，總價值為 75,290,000.00 美元。交易完成後，該董事直接持有該公司 3,222,108 股股票，價值 1,212,962,556.60 美元。此次交易使其持股減少了 5.84%。該出售在向 SEC 的法律文件中披露，文件可在此鏈接查看。此外，內部人士 Viju Menon 於 8 月 25 日（星期一）出售了 500 股史賽克股票，交易發生在該股票的平均價格為 390.61 美元，總價值為 195,305.00 美元。交易完成後，該內部人士持有該公司約 12,511 股股票，價值約 4,886,921.71 美元。該出售的披露可在此處找到。內部人士持有該公司 5.20% 的股票。</p>
<h2>史賽克簡介</h2>
<p>（免費報告）</p>
<p>史賽克公司是一家醫療技術公司。該公司通過兩個部門運營，分別是醫療外科和神經技術，以及骨科和脊柱。骨科和脊柱部門提供用於全關節置換的植入物，如髖關節、膝關節和肩關節，以及創傷和四肢手術。</p>
<h2>精選故事</h2>
<ul>
<li>五隻我們認為比史賽克更好的股票</li>
<li>如何利用分析師評級進行交易</li>
<li>EA 550 億美元交易引發遊戲行業震盪</li>
<li>三隻小盤股具有巨大的回報潛力</li>
<li>這些是第三季度盈利增長的三大熱門行業</li>
<li>股票交易術語 - 每位投資者需要了解的股票術語</li>
<li>AMD 可能會在此基礎上翻倍——得益於其與 OpenAI 的重磅交易</li>
</ul>
<p><strong>想看看其他對 SYK 持有的對沖基金嗎？</strong> 請訪問 HoldingsChannel.com，獲取史賽克公司（NYSE:SYK - 免費報告）的最新 13F 文件和內部交易信息。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVNZSw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVNZSw"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。如對該故事有任何問題或意見，請發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在史賽克嗎？</h2>
<p>在考慮史賽克之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户在更廣泛的市場注意到之前購買的股票……而史賽克並不在名單上。</p>
<p>雖然史賽克目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

史賽克

<p>Hendley & Co. Inc. 在第二季度將其在史賽克（NYSE:SYK）的持股增加了 60.3%，目前持有 14,018 股，價值為 555 萬美元。其他對沖基金也調整了他們的持倉，機構投資者持有該股票的比例為 77.09%。史賽克的股票開盤價為 369.14 美元，市值為 1411.2 億美元。該公司報告第二季度每股收益為 3.13 美元，超出預期，並宣佈季度股息為 0.84 美元。分析師維持 “適度買入” 的共識，平均目標價為 430.10 美元</p>

<p>Hendley &amp; Co. Inc. raised its stake in Stryker Corporation (NYSE:SYK - Free Report) by 60.3% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 14,018 shares of the medical technology company's stock after purchasing an additional 5,274 shares during the quarter. Stryker comprises about 1.9% of Hendley &amp; Co. Inc.'s investment portfolio, making the stock its 18th biggest position. Hendley &amp; Co. Inc.'s holdings in Stryker were worth $5,546,000 as of its most recent filing with the Securities and Exchange Commission (SEC).</p>
<div class="lb-trans"><p>Hendley &amp; Co. Inc. 在最近向證券交易委員會（SEC）提交的 13F 表格中披露，在第二季度將其在史賽克公司的股份提高了 60.3%。該公司在季度內額外購買了 5,274 股後，持有該醫療科技公司 14,018 股股票。史賽克約佔 Hendley &amp; Co. Inc. 投資組合的 1.9%，使其成為該公司第 18 大持倉。根據 Hendley &amp; Co. Inc. 最近向證券交易委員會（SEC）提交的文件，其在史賽克的持股價值為 5,546,000 美元。</p>
</div><ul>
<li>If You Could Only Hold 3 Investments for Life, Consider These</li>
</ul>
<div class="lb-trans"><ul>
<li>如果你只能持有 3 項投資一輩子，請考慮這些</li>
</ul>
</div><p>Other hedge funds also recently added to or reduced their stakes in the company. Mogy Joel R Investment Counsel Inc. raised its position in Stryker by 3.4% in the first quarter. Mogy Joel R Investment Counsel Inc. now owns 98,216 shares of the medical technology company's stock valued at $36,561,000 after purchasing an additional 3,218 shares during the period. Ferguson Wellman Capital Management Inc. raised its position in Stryker by 1.9% in the first quarter. Ferguson Wellman Capital Management Inc. now owns 174,871 shares of the medical technology company's stock valued at $65,096,000 after purchasing an additional 3,341 shares during the period. Harbor Capital Advisors Inc. purchased a new position in Stryker in the first quarter valued at about $1,840,000. Mar Vista Investment Partners LLC increased its position in shares of Stryker by 10.2% during the first quarter. Mar Vista Investment Partners LLC now owns 90,187 shares of the medical technology company's stock worth $33,572,000 after acquiring an additional 8,353 shares during the last quarter. Finally, United Services Automobile Association purchased a new stake in shares of Stryker during the first quarter worth about $2,857,000. 77.09% of the stock is owned by hedge funds and other institutional investors.</p>
<div class="lb-trans"><p>其他對沖基金最近也增加或減少了在該公司的股份。Mogy Joel R Investment Counsel Inc. 在第一季度將其在史賽克的持倉提高了 3.4%。Mogy Joel R Investment Counsel Inc. 現在持有 98,216 股該醫療科技公司的股票，價值 36,561,000 美元，在此期間又購買了 3,218 股。Ferguson Wellman Capital Management Inc. 在第一季度將其在史賽克的持倉提高了 1.9%。Ferguson Wellman Capital Management Inc. 現在持有 174,871 股該醫療科技公司的股票，價值 65,096,000 美元，在此期間又購買了 3,341 股。Harbor Capital Advisors Inc. 在第一季度購買了價值約 1,840,000 美元的史賽克新股份。Mar Vista Investment Partners LLC 在第一季度將其在史賽克的股份增加了 10.2%。Mar Vista Investment Partners LLC 現在持有 90,187 股該醫療科技公司的股票，價值 33,572,000 美元，在上個季度又收購了 8,353 股。最後，聯合服務汽車協會在第一季度購買了價值約 2,857,000 美元的史賽克新股份。77.09% 的股票由對沖基金和其他機構投資者持有。</p>
</div><h2>Stryker Stock Up 0.8%</h2>
<div class="lb-trans"><h2>史賽克股票上漲 0.8%</h2>
</div><p>Shares of Stryker stock opened at $369.14 on Wednesday. The company has a quick ratio of 1.06, a current ratio of 1.78 and a debt-to-equity ratio of 0.70. The firm has a market cap of $141.12 billion, a P/E ratio of 48.89, a P/E/G ratio of 2.64 and a beta of 0.94. Stryker Corporation has a fifty-two week low of $329.16 and a fifty-two week high of $406.19. The business has a 50-day moving average price of $381.50 and a 200 day moving average price of $378.86.</p>
<div class="lb-trans"><p>史賽克股票週三開盤價為 369.14 美元。該公司的速動比率為 1.06，流動比率為 1.78，債務與股本比率為 0.70。該公司的市值為 1411.2 億美元，市盈率為 48.89，市盈增長比率為 2.64，貝塔值為 0.94。史賽克公司的 52 周低點為 329.16 美元，52 周高點為 406.19 美元。該公司的 50 日移動平均價格為 381.50 美元，200 日移動平均價格為 378.86 美元。</p>
</div><ul>
<li>3 Stocks Helping to Bring AI to Healthcare</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只幫助將人工智能引入醫療保健的股票</li>
</ul>
</div><p>Stryker (NYSE:SYK - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The medical technology company reported $3.13 earnings per share for the quarter, beating the consensus estimate of $3.07 by $0.06. The firm had revenue of $6.02 billion during the quarter, compared to analyst estimates of $5.92 billion. Stryker had a return on equity of 23.94% and a net margin of 12.25%.Stryker's quarterly revenue was up 11.1% on a year-over-year basis. During the same period in the previous year, the company earned $2.81 earnings per share. Stryker has set its FY 2025 guidance at 13.400-13.600 EPS. On average, sell-side analysts forecast that Stryker Corporation will post 13.47 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>史賽克（NYSE:SYK - 獲取免費報告）最近在 7 月 31 日（星期四）公佈了季度財報。該醫療科技公司報告季度每股收益為 3.13 美元，超出市場共識預期的 3.07 美元，超出 0.06 美元。該公司在季度內的收入為 60.2 億美元，而分析師預期為 59.2 億美元。史賽克的股本回報率為 23.94%，淨利潤率為 12.25%。與去年同期相比，史賽克的季度收入增長了 11.1%。在去年同期，該公司每股收益為 2.81 美元。史賽克已將其 2025 財年的指導目標設定為 13.400-13.600 每股收益。平均而言，賣方分析師預測史賽克公司本財年的每股收益為 13.47 美元。</p>
</div><h2>Stryker Announces Dividend</h2>
<div class="lb-trans"><h2>史賽克宣佈分紅</h2>
</div><p>The business also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Tuesday, September 30th will be paid a $0.84 dividend. This represents a $3.36 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date is Tuesday, September 30th. Stryker's payout ratio is presently 44.50%.</p>
<div class="lb-trans"><p>該公司最近還宣佈了季度分紅，將於 10 月 31 日（星期五）支付。9 月 30 日（星期二）登記的股東將獲得 0.84 美元的分紅。這相當於年化 3.36 美元的分紅，收益率為 0.9%。除息日為 9 月 30 日（星期二）。史賽克的派息比率目前為 44.50%。</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析師設定新目標價</h2>
</div><ul>
<li>Boston Scientific: Why This MedTech Giant Isn’t Slowing Down</li>
</ul>
<div class="lb-trans"><ul>
<li>波士頓科學：為什麼這家醫療科技巨頭沒有放慢腳步</li>
</ul>
</div><p>A number of brokerages have recently issued reports on SYK. BTIG Research reaffirmed a &#34;buy&#34; rating on shares of Stryker in a research report on Monday, July 14th. Redburn Partners set a $420.00 target price on Stryker in a research report on Thursday, September 18th. Weiss Ratings reaffirmed a &#34;buy (b-)&#34; rating on shares of Stryker in a research report on Saturday, September 27th. Wells Fargo &amp; Company lifted their target price on Stryker from $435.00 to $445.00 and gave the stock an &#34;overweight&#34; rating in a research report on Friday, August 1st. Finally, Rothschild Redb raised Stryker to a &#34;hold&#34; rating in a research report on Thursday, September 18th. Fifteen investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of &#34;Moderate Buy&#34; and an average price target of $430.10.</p>
<div class="lb-trans"><p>多家券商最近對 SYK 發佈了報告。BTIG Research 在 7 月 14 日（星期一）的研究報告中重申了對史賽克股票的 “買入” 評級。Redburn Partners 在 9 月 18 日（星期四）的研究報告中將史賽克的目標價設定為 420.00 美元。Weiss Ratings 在 9 月 27 日（星期六）的研究報告中重申了對史賽克股票的 “買入（b-）” 評級。富國銀行在 8 月 1 日（星期五）的研究報告中將史賽克的目標價從 435.00 美元上調至 445.00 美元，並給予該股票 “超配” 評級。最後，Rothschild Redb 在 9 月 18 日（星期四）的研究報告中將史賽克的評級上調至 “持有”。十五位投資分析師對該股票給予了買入評級，六位分析師對該公司給予了持有評級。根據 MarketBeat.com 的數據，該公司的共識評級為 “適度買入”，平均目標價為 430.10 美元。</p>
</div><p><strong>Read Our Latest Research Report on Stryker</strong></p>
<div class="lb-trans"><p><strong>閲讀我們關於史賽克的最新研究報告</strong></p>
</div><h2>Insider Buying and Selling</h2>
<div class="lb-trans"><h2>內部買賣</h2>
</div><p>In other Stryker news, Director Ronda E. Stryker sold 200,000 shares of Stryker stock in a transaction that occurred on Wednesday, August 6th. The stock was sold at an average price of $376.45, for a total value of $75,290,000.00. Following the completion of the transaction, the director directly owned 3,222,108 shares in the company, valued at $1,212,962,556.60. The trade was a 5.84% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Viju Menon sold 500 shares of Stryker stock in a transaction that occurred on Monday, August 25th. The shares were sold at an average price of $390.61, for a total value of $195,305.00. Following the completion of the transaction, the insider owned 12,511 shares of the company's stock, valued at approximately $4,886,921.71. The trade was a 3.84% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 5.20% of the company's stock.</p>
<div class="lb-trans"><p>在其他史賽克新聞中，董事 Ronda E. Stryker 於 8 月 6 日（星期三）出售了 200,000 股史賽克股票，交易發生在該股票的平均價格為 376.45 美元，總價值為 75,290,000.00 美元。交易完成後，該董事直接持有該公司 3,222,108 股股票，價值 1,212,962,556.60 美元。此次交易使其持股減少了 5.84%。該出售在向 SEC 的法律文件中披露，文件可在此鏈接查看。此外，內部人士 Viju Menon 於 8 月 25 日（星期一）出售了 500 股史賽克股票，交易發生在該股票的平均價格為 390.61 美元，總價值為 195,305.00 美元。交易完成後，該內部人士持有該公司約 12,511 股股票，價值約 4,886,921.71 美元。該出售的披露可在此處找到。內部人士持有該公司 5.20% 的股票。</p>
</div><h2>Stryker Profile</h2>
<div class="lb-trans"><h2>史賽克簡介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免費報告）</p>
</div><p>Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.</p>
<div class="lb-trans"><p>史賽克公司是一家醫療技術公司。該公司通過兩個部門運營，分別是醫療外科和神經技術，以及骨科和脊柱。骨科和脊柱部門提供用於全關節置換的植入物，如髖關節、膝關節和肩關節，以及創傷和四肢手術。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精選故事</h2>
</div><ul>
<li>Five stocks we like better than Stryker</li>
<li>How to trade using analyst ratings</li>
<li>EA’s $55 Billion Deal Spurs a Shake-Up in the Gaming Sector</li>
<li>3 Small Caps With Big Return Potential</li>
<li>These Are the 3 Hottest Sectors for Q3 Earnings Growth</li>
<li>Stock Trading Terms - Stock Terms Every Investor Needs to Know</li>
<li>AMD Could Double From Here—Thanks to Its Blockbuster OpenAI Deal</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們認為比史賽克更好的股票</li>
<li>如何利用分析師評級進行交易</li>
<li>EA 550 億美元交易引發遊戲行業震盪</li>
<li>三隻小盤股具有巨大的回報潛力</li>
<li>這些是第三季度盈利增長的三大熱門行業</li>
<li>股票交易術語 - 每位投資者需要了解的股票術語</li>
<li>AMD 可能會在此基礎上翻倍——得益於其與 OpenAI 的重磅交易</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding SYK?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他對 SYK 持有的對沖基金嗎？</strong> 請訪問 HoldingsChannel.com，獲取史賽克公司（NYSE:SYK - 免費報告）的最新 13F 文件和內部交易信息。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVNZSw" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=SYK"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。如對該故事有任何問題或意見，請發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Stryker Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在史賽克嗎？</h2>
</div><p>Before you consider Stryker, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮史賽克之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stryker wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户在更廣泛的市場注意到之前購買的股票……而史賽克並不在名單上。</p>
</div><p>While Stryker currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然史賽克目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Hendley & Co. Inc. 購買了史賽克公司 $SYK 的股票